Eris Lifesciences Limited has informed the Exchange about Schedule of meet
Suven Pharmaceuticals Limited has informed the Exchange regarding Cessation of Mr Chandrasekhar Srivari as Non- Executive Independent Director of the company w.e.f. January 19, 2022.
TATA CONSUMER PRODUCTS LIMITED has informed the Exchange about Loss of Share Certificates
Housing Development and Infrastructure Limited
Eicher Motors Limited has informed the Exchange about Loss of Share Certificates
Dwarikesh Sugar Industries Limited has informed the Exchange about Copy of Newspaper Publication
Newgen Software Technologies Limited with respect to announcement dated 18-Jan-2022, regarding? Incorporation of a wholly owned subsidiary in UAE. On basis of above the Company is required to clarify following: 1. Name of the target entity, details in brief such as size, turnover etc; 2. Whether the acquisition would fall within related party transactions and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at arms length; 3. Industry to which the entity being acquired belongs; 4. Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity); 5. Brief details of any governmental or regulatory approvals required for the acquisition; 6. Indicative time period for completion of the acquisition; The response of the Company is awai
Walpar Nutritions Limited with respect to announcement dated 11-Jan-2022, regarding resignation of Mr. Parin Patel as Independent Director of the company w.e.f. January 11, 2022. On basis of above the Company is required to clarify following:?1. Confirmation from the resigning director that there are no other material reasons other than provided; 2. ?The Letter of resignation of the independent director mentioning the detailed reasons for the resignation; 3. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any. The response of the Company is awaited.
HFCL Limited has informed the Exchange regarding Litigation(s) / dispute(s) / regulatory action(s) with impact.
Chemplast Sanmar Limited has informed the Exchange regarding Change in Corporate Identity Number of the Company.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.